Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy

European Journal of Clinical Pharmacology

Volumn 55, Issue 9, 1999, Pages 685-690

  Tognoni, Gianni ^a   Alison, P ^b   Amato, U ^b   Angelatos, M P ^b   Arcari, S ^b   Argentiero, I ^b   Balzani, A ^b   Barbagallo, C ^b   Barbui, C ^b   Bertoldin, T ^b   Bianchetti, M ^b   Bonini, D ^b   Bracco, R ^b   Caldarone, D ^b   Callegari, V ^b   Capodieci, B ^b   Caprino, V ^b   Cardamone, G ^b   Castellano, A ^b   D'Elia, A ^b   DePaolis, G ^b   Di Benedetto, P ^b   Donisi, R ^b   Dramisino, G ^b   Errico, M ^b   Evaristo, P ^b   Falavolti, S ^b   Ferrari, G ^b   Forte, G ^b   Galli, C ^b   Garofalo, A ^b   Giudiceandrea, A ^b   Gracco, F ^b   Grasso, F ^b   Gregorutti, C ^b   Guarnieri, A ^b   Gugliotta, M ^b   Interlandi, G ^b   Karavalaki, I ^b   Laddomada, F ^b   Lieti, M ^b   Liguori, G ^b   Loparco, N ^b   Lorenzetti, M P ^b   Maestra, M R ^b   Mangione, C ^b   Marani, S ^b   Marchetti, A P ^b   Mareschi, N ^b   Mari, L ^b   Marzullo, F ^b   Materzanini, A ^b   Mazzarda, A ^b   Mazze R ^b   Mazzuia, P ^b   Mengano, A ^b   Musazzi, A ^b   Novello, M ^b   Panza, G ^b   Pappalardo, L ^b   Pardi, G ^b   Pederzoli, L ^b   Pismataro, C P ^b   Primiani, G ^b   Provenzano, S ^b   Punzo, F ^b   Ranieri, L ^b   Raspini, V ^b   Re, E ^b   Ricciardelli, F ^b   Ritacco, A ^b   Rossini, R ^b   Ruggeri, A ^b   Scala, A ^b   Scarani, G ^b   Schneider, M G ^b   Storer, C ^b   Tauriello, A ^b   Terzian, E ^b   Tinagli, A ^b   Valletta, M ^b   Yurincic, M ^b   Zuccolo, D ^b   more..

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b NONE

Author keywords

Drug utilisation study; Psychiatric outpatient services; Psychotropic drug use

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; HALOPERIDOL; LITHIUM; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; DRUG UTILIZATION; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; OUTPATIENT CARE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0032711704     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050694     Document Type: Article

References (28)

1. 1. Dukes MNG (1993) Drug utilization studies. WHO Regional Publications, European Series, No. 45, Copenaghen
2. 2. Tognoni G, Bellantuono C, Lader M (1981) Epidemiological impact of psychotropic drugs. Elsevier/North-Holland Biomedical Press, Amsterdam
3. 3. de Girolamo G, Cappiello V (1993) Gli studi di drug-utilization in psichiatria: una review. Riv Psichiatria 28: 133-142
4. 4. Bellantuono C, Reggi V, Tognoni G, Muscettola G (1981) Comparison of practice in hospitals and community mental health centres. In: Tognoni G, Bellantuono C, Lader M (eds) Epidemiological impact of psychotropic drugs. Elsevier/North-Holland Biomedical Press, Amsterdam, pp 171-181
5. 5. Muscettola G, Casiello M, Bollini P, Sebastiani G, Pampallona S, Tognoni G (1987) Pattern of therapeutic interventions and role of psychiatric settings: a survey in two regions of Italy. Acta Psychiatr Scand 75: 55-61
6. 6. Muscettola G, Bollini P, Pampallona S (1991) Pattern of neuroleptic drug use in Italian mental health services. Ann Pharmacother 25: 296-301
7. 7. Munizza C, Tibaldi G, Bollini P, Pirfo E, Punzo F, Gramaglia F (1996) Prescription pattern of antidepressants in out-patient psychiatric practice. Psychol Med 25: 771-778
8. 8. Tibaldi G, Munizza C, Bollini P, Pirfo E, Punzo F, Gramaglia MS (1997) Utilization of neuroleptic drugs in Italian mental health services: a survey in Piedmont. Psychiatr Serv 48: 213-217
9. 9. Terzian E, Sternai E, Barbato A, Tognoni G, Saraceno B (1997) Epidemiology of psychiatric care of patients with severe mental disorders in Italy. Rationale and design of a prospective study, and characteristics of the cohort. Soc Psychiatry Psychiatr Epidemiol 32: 298-302
10. 10. WHO Collaborating Centre for Drug Statistic Methodology (1996) Guidelines for ATC classification and DDD assignment. WHO, Oslo
11. 11. Jacob KS (1995) The use of multiple psychotropic medication in the treatment of mental disorders. Aust NZ J Psychiatry 29: 186-188
12. 12. Rosenheck R, Cramer J, Weichun BS, Thomas J, Henderson W, Frisman L (1997) A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Engl J Med 337: 809-815
13. 13. Mendelowitz AJ, Gerson SL, Alvir JMJ, Lieberman JA (1995) Clozapine-induced agranulocytosis. Risk factors, monitoring and management. CNS Drugs 4: 412-421
14. 14. Horton R (1996) Prizes, publications, and promotion. Lancet 348: 1398
15. 15. Bondolfi G (1996) Treatment resistant schizophrenia: clinical experience with new antipsychotics. Eur Neuropharmacol 6: s2-s21
16. 16. Konrad C, Schormair C, Knickelbein U (1997) Risperidone and clozapine in pharmaco-resistant schizophrenia (abstract). Proceedings of the American Psychiatric Association Meeting 1997
17. 17. Mattes JA (1997) Risperidone: how good is the evidence for efficacy? Schizophr Bull 23: 155-161
18. 18. Llerena A, Kiivet RA (1994) Fixed combinations of neuroleptics with antidepressants: potential risks and estimation of use. Br J Clin Pharmacol 37: 531-532
19. 19. Weilburg JB, Rosenbaum JF, Biederman MD, Sachs GS, Pollack MH, Kelly K (1989) Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry 50: 447-449
20. 20. Andrews J, Nemeroff C (1994) Contemporary management of depression. Am J Med 97: 245-325
21. 21. Nieremberg AA, Cole JO, Glass L (1994) Possible trazodone potentiation of fluoxetine: a case series. J Clin Psychiatry 53: 83-85
22. 22. Nieremberg AA, McColl RD (1996) Management options for refractory depression. Am J Med 101[suppl 6A]: 45S-52S
23. 23. Aranow A, Hudson J, Pope H (1989) Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry 146: 911-913
24. 24. Silverstone T, Romans S (1996) Long-term treatment of bipolar disorder. Drugs 51: 367-382
25. 25. Yatham LN, Kusumakar V, Parikh SV, Haslam DRS, Matte R, Sharma V, Kennedy S (1997) Bipolar depression: treatment options. Can J Psychiatry 42[suppl 2]: 87S-91S
26. 26. Stein G (1992) Drug treatment of the personality disorders. Br J Psychiatry 161: 167-184
27. 27. Marlowe M, Sugarman P (1997) Disorders of the personality. BMJ 315: 176-179
28. 28. Dichter MA, Brodie MJ (1996) New antiepileptic drugs. N Engl J Med 334: 1583-1590